ADDED
As of March 30, 2026, the Registrant had 5,951,030 ordinary shares outstanding (inclusive of shares included in our units).
Recent Developments RDAC held its Extraordinary General Meeting of shareholders (the EGM ) on November 20, 2025.
As of September 11, 2025, the record date for the EGM, there were 7,499,375 ordinary shares entitled to vote at the EGM.
At the EGM, there were 5,049,309 ordinary shares voted by proxy or in person, representing 67.33% of the ordinary shares issued and outstanding and entitled to vote at the EGM as of the record date and constituting a quorum for the transaction of business.
the Reincorporation Merger Proposal, the Acquisition Merger Proposal, the Nasdaq Proposal, the PubCo Charter Proposal, the Director Approval Proposal, and the Adjournment Proposal, were approved by the shareholders.
In connection with the shareholders vote at the EGM, 5,715,609 ordinary shares were tendered for redemption.
RDAC held its Extraordinary General Meeting of shareholders (the Extension Meeting ) on December 12, 2025.
As of September 11, 2025, the record date for the Extension Meeting, there were 7,499,375 ordinary shares entitled to vote at the Extension Meeting.
At the Extension Meeting, there were 5,165,854 ordinary shares voted by proxy or in person, representing 68.88% of the Company s ordinary shares issued and outstanding and entitled to vote at the Extension Meeting as of the record date and constituting a quorum for the transaction of business.
the Trust Agreement Amendment Proposal and the Adjournment Proposal, were approved by the shareholders at the Extension Meeting.
REMOVED
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.
Therefore, the aggregate market value of the Registrant s ordinary shares held by non-affiliates of the Registrant was $ 0 .
As of March 26, 2025, the Registrant had 7,499,375 ordinary shares outstanding (inclusive of shares included in our units).
Financial Position With a trust account initially in the amount of $50,750,000 (or $58,287,500 if the over-allotment option is exercised in full) (which includes up to approximately $1,625,000 (or up to $1,868,750 if the over-allotment option is exercised in full), for the payment of deferred underwriting discounts), we can offer a target business a variety of options to facilitate a business combination and fund future expansion and growth of its business.
As of December 31, 2024, the Company had cash of $392,679 and a working capital equity of $433,179.
Holders of Record As of March 26, 2025, there were 7,499,375 (inclusive of ordinary shares included in our units) of our ordinary shares issued and outstanding, held by a total of ten record holders.
22 Securities Authorized for Issuance Under Equity Compensation Plans None.
For the year ended December 31, 2024, we had a net income of $257,513, which consisted of interest earned on marketable securities held in the Trust Account of $543,046, offset by formation and operational costs of $285,533.
Liquidity and Capital Resources For the year ended December 31, 2024, cash used in operating activities was $326,033.
Net income of $257,513 was affected by formation and operational costs of $285,533, interest earned on marketable securities held in the Trust Account of $543,046.